Namdar H, Khani E, Khiali S, Safaie N, Ameli H, Rahbari Banaeian G, Entezari-Maleki T. Effects of citalopram on blood pressure control in depressive patients with hypertension: A randomized clinical trial.
J Cardiovasc Thorac Res 2024;
16:49-54. [PMID:
38584664 PMCID:
PMC10997981 DOI:
10.34172/jcvtr.31849]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2023] [Accepted: 01/27/2024] [Indexed: 04/09/2024] Open
Abstract
Introduction
Since there is a bi-directional interaction between hypertension and depression, we aimed to evaluate the effects of citalopram administration in the management of hypertension.
Methods
A randomized clinical trial was conducted on 72 patients with concomitant depression and hypertension. The intervention group (n=41) received citalopram 20 mg daily plus anti-hypertensive standard treatment, while the control group (n=31) received only the standard treatment. The study's primary endpoint was in-office blood pressure (BP) measurement at baseline and home BP monitoring in the first and second months after entering the study.
Results
There were no significant differences in baseline systolic BP (163.3±19.6 vs.164.2±20.3 mm Hg; P=0.910) and diastolic BP (94.5±13.8 vs. 88.2±14.4; P=0.071). After one month, diastolic BP (82.7±11.7 vs. 77.09±12.2; P=0.023) was significantly higher in the control group compared to the intervention group. Two months after the intervention, systolic BP (133.8±16.5 vs. 124.5±12.4; P=0.009) and diastolic BP (80.7±10.3 vs. 73.7±9.7; P=0.002) were significantly decreased in the intervention group compared to the control group.
Conclusion
This study supported the beneficial effects of citalopram in lowering BP in patients with concomitant depression and hypertension.
Collapse